The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Long-Term Outcome of 444 Patients with Distant Metastases from Papillary and Follicular Thyroid Carcinoma: Benefits and Limits of Radioiodine Therapy
Abstract
AIM: The goal of this study was to estimate the cumulative activity of (131)I to be administered to patients with distant metastases from thyroid carcinoma. METHODS: A total of 444 patients were treated from 1953-1994 for distant metastases from papillary and follicular thyroid carcinoma: 223 had lung metastases only, 115 had bone metastases only, 82 had both lung and bone metastases, and 24 had metastases at other sites. Treatment consisted of the administration of 3.7 GBq (100 mCi) (131)I after withdrawal of thyroid hormone treatment, every 3-9 months during the first 2 yr and then once a year until the disappearance of any metastatic uptake. Thyroxine treatment was given at suppressive doses between (131)I treatment courses. RESULTS: Negative imaging studies (negative total body (131)I scans and conventional radiographs) were attained in 43% of the 295 patients with (131)I uptake; more frequently in those who were younger, had well-differentiated tumors, and had a limited extent of disease. Most negative studies (96%) were obtained after the administration of 3.7-22 GBq (100-600 mCi). Almost half of negative studies were obtained more than 5 yr after the initiation of the treatment of metastases. Among patients who achieved a negative study, only 7% experienced a subsequent tumor recurrence. Overall survival at 10 yr after initiation of (131)I treatment was 92% in patients who achieved a negative study and 19% in those who did not. CONCLUSION: (131)I treatment is highly effective in younger patients with (131)I uptake and with small metastases. They should be treated until the disappearance of any uptake or until a cumulative activity of 22 GBq has been administered. In the other patients, other treatment modalities should be used when tumor progression has been documented.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
Mazzaferri, E. L. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1447 · Cited by 1,396
Laboratory Support for the Diagnosis and Monitoring of Thyroid Disease
(2003) · Thyroid · doi:10.1089/105072503321086962 · Cited by 1,212
Ackerman, L. V., & Rosaí, J. (1974) · Medical Entomology and Zoology · Cited by 1,043
Second primary malignancies in thyroid cancer patients
Rubino, C., de Vathaire, F., Dottorini, M. E., Hall, P., Schvartz, C., Couette, J. E., Dondon, M. G., Abbas, M. T., Langlois, C., & Schlumberger, M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601319 · Cited by 655
Self-citationHistological Typing of Thyroid Tumours
Hedinger, C. (1988) · Springer eBooks · doi:10.1007/978-3-642-61383-8 · Cited by 630
Robbins, R. J., Wan, Q., Grewal, R. K., Reibke, R., Gonen, M., Strauss, H. W., Tuttle, R. M., Drucker, W., & Larson, S. M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1534 · Cited by 587
Schlumberger, M. J., Vathaire, C. C.-D., de Vathaire, F., Travagli, J. P., Gardet, P., Lumbroso, J., Francese, C., Fontaine, F., Ricard, M., & Parmentier, C. (1996) · PubMed · Cited by 498
Self-citationShimaoka, K., Schoenfeld, D. A., Dewys, W. D., Creech, R. H., & Deconti, R. (1985) · Cancer · doi:10.1002/1097-0142(19851101)56:9<2155::aid-cncr2820560903>3.0.co;2-e · Cited by 464
Demers, L. M., & Spencer, C. A. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01681.x · Cited by 460
Radioiodsne-131 In the Diagnosis and Treatment of Metastatic Weil Differentiated Thyroid Cancer
Maxon, H. R., & Smith, H. S. (1990) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30317-7 · Cited by 409
Radioactive Iodine and the Salivary Glands
Mandel, S. J., & Mandel, L. (2003) · Thyroid · doi:10.1089/105072503321582060 · Cited by 375
Bernier, M.-O. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.4.1568 · Cited by 299
Baudin, E., Cao, C. D., Cailleux, A. F., Leboulleux, S., Travagli, J. P., & Schlumberger, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021365 · Cited by 278
Self-citationDinneen, S. F. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.7.2041 · Cited by 275
Pacini, F. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4092 · Cited by 268
External radiotherapy in thyroid cancers
Tubiana, M., Haddad, E., Schlumberger, M. J., Hill, C., Rougier, P. R., & Sarrazin, D. (1985) · Cancer · doi:10.1002/1097-0142(19850501)55:9+<2062::aid-cncr2820551406>3.0.co;2-o · Cited by 225
Self-citationThyroid-hormone therapy and thyroid cancer: a reassessment
Biondi, B., Filetti, S., & Schlumberger, M. (2005) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0020 · Cited by 224
Self-citationPittas, A. G., Adler, M., Fazzari, M., Tickoo, S., Rosai, J., Larson, S. M., & Robbins, R. J. (2000) · Thyroid · doi:10.1089/thy.2000.10.261 · Cited by 224
Casara, D., Rubello, D., Saladini, G., Masarotto, G., Favero, A., Girelli, M. E., & Busnardo, B. (1993) · PubMed · Cited by 212
131 I Therapy for Elevated Thyroglobulin Levels
SCHLUMBERGER, M., MANCUSI, F., BAUDIN, E., & PACINI, F. (1997) · Thyroid · doi:10.1089/thy.1997.7.273 · Cited by 208
Self-citationThe evolving role of (131)I for the treatment of differentiated thyroid carcinoma.
Robbins, R. J., & Schlumberger, M. J. (2005) · PubMed · Cited by 181
Self-citationOutcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine
Pacini, F., Cetani, F., Miccoli, P., Mancusi, F., Ceccarelli, C., Lippi, F., Martino, E., & Pinchera, A. (1994) · World Journal of Surgery · doi:10.1007/bf00353775 · Cited by 175
Nasolacrimal Drainage System Obstruction from Radioactive Iodine Therapy for Thyroid Carcinoma
Kloos, R. T., Duvuuri, V., Jhiang, S. M., Cahill, K. V., Foster, J. A., & Burns, J. A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020210 · Cited by 169
Williams, S. D., Birch, R., & Einhorn, L. H. (1986) · PubMed · Cited by 126
Chemotherapy in Metastatic Nonanaplastic Thyroid Cancer: Experience at the Institut Gustave-Roussy
Droz, J., Schlumberger, M. J., Rougier, P. R., Ghosn, M., Gardet, P., & Parmentier, C. (1990) · Tumori Journal · doi:10.1177/030089169007600513 · Cited by 110
Self-citationBeyond Radioiodine: A Review of Potential New Therapeutic Approaches for Thyroid Cancer
Braga‐Basaria, M., & Ringel, M. D. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021863 · Cited by 101
Papillary Thyroid Carcinomas with Lung Metastases
Lin, J., Chao, T., Chou, S.-C., & Hsueh, C. (2004) · Thyroid · doi:10.1089/thy.2004.14.1091 · Cited by 81
Current status of radioiodine (^ I) treatment of hyperthyroidism
Becker, D. (1982) · Medical Entomology and Zoology · Cited by 5
Cited by
Haugen, B. R., Alexander, E. K., Bible, K. C., Doherty, G. M., Mandel, S. J., Nikiforov, Y. E., Pacini, F., Randolph, G. W., Sawka, A. M., Schlumberger, M., et al. (2016) · Thyroid® · doi:10.1089/thy.2015.0020 · Cited by 16,535
Self-citationCooper, D. S., Doherty, G. M., Haugen, B. R., Kloos, R. T., Lee, S. L., Mandel, S. J., Mazzaferri, E. L., McIver, B., Pacini, F., Schlumberger, M., et al. (2009) · Thyroid · doi:10.1089/thy.2009.0110 · Cited by 6,707
Self-citationLenvatinib versus Placebo in Radioiodine-Refractory Thyroid Cancer
Schlumberger, M., Tahara, M., Wirth, L. J., Robinson, B., Brose, M. S., Elisei, R., Habra, M. A., Newbold, K., Shah, M. H., Hoff, A. O., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1406470 · Cited by 2,096
Self-citationBrose, M. S., Nutting, C. M., Jarzab, B., Elisei, R., Siena, S., Bastholt, L., de la Fouchardiere, C., Pacini, F., Paschke, R., Shong, Y. K., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(14)60421-9 · Cited by 1,663
Self-citationCabanillas, M. E., McFadden, D. G., & Durante, C. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30172-6 · Cited by 1,430
Self-citation
Metadata
- Authors
- Durante, C., Haddy, N., Baudin, E., Leboulleux, S., Hartl, D., Travagli, J. P., Caillou, B., Ricard, M., Lumbroso, J. D., De Vathaire, F., & Schlumberger, M.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2006-08-01
- Volume
- 91
- Issue
- 8
- Pages
- 2892-2899
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2040642592
- Cited by
- 1,675
- References
- 28
- FWCI
- 19.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.